Lymphotoxic effect of cyclophosphamide in therapy of Ehrlich ascites carcinoma in mice.
D000818:Animals; D000951:Antigens, Neoplasm / Q000008:administration & dosage / Q000528:radiation effects; D001853:Bone Marrow / Q000187:drug effects / Q000473:pathology; D001854:Bone Marrow Cells; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D002470:Cell Survival / Q000187:drug effects; D003520:Cyclophosphamide / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D007165:Immunosuppression Therapy; D008198:Lymph Nodes / Q000187:drug effects / Q000473:pathology; D008221:Lymphoid Tissue / Q000187:drug effects*; D008297:Male; D051379:Mice; D013154:Spleen / Q000187:drug effects / Q000473:pathology; D013950:Thymus Gland / Q000187:drug effects / Q000473:pathology
D000951:Antigens, Neoplasm; D003520:Cyclophosphamide